← Open Payments lookup

ASHEE AMJAD AMJAD WARYAM: Open Payments

NPI 1760920391 · MERCED, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,676 in 144 payments from 11 companies in 2025. Trend: 2023 $1,636 · 2024 $1,965 · 2025 $2,676

Food & beverage: $2,676
CompanyPaymentsAmount
ABBVIE INC.49$919
Janssen Pharmaceuticals, Inc28$486
Otsuka America Pharmaceutical, Inc.31$450
Teva Pharmaceuticals USA, Inc.17$292
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$262
Lundbeck LLC4$78
Neurocrine BioSciences, Inc.3$66
Alkermes, Inc.2$48
Takeda Pharmaceuticals U.S.A., Inc.2$43
Almatica Pharma LLC1$18

Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, AUSTEDO XR, CAPLYTA, ABILIFY ASIMTUFII, SPRAVATO, INGREZZA.

Industry payments across CA — which companies pay providers there.